Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
March 6, 2004
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
Livio Trentin, Anna Cabrelle, Monica Facco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis
Isabella Dell'Aica, Raffaele Niero, Francesco Piazza, et al.
Thorax
|
December 9, 2010
Sarcoidosis is a Th1/Th17 multisystem disorder
Monica Facco, Anna Cabrelle, Antonella Teramo, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Journal of Leukocyte Biology
|
July 7, 2007
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis
Monica Facco, Ilenia Baesso, Marta Miorin, et al.
Plos One
|
July 7, 2012
HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen
Federica Frezzato, Cristina Gattazzo, Veronica Martini, et al.
British Journal of Haematology
|
August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity
Livio Trentin, Marta Miorin, Monica Facco, et al.
Blood
|
May 17, 2003
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes
Renato Zambello, Michela Falco, Mariella Della Chiesa, et al.
Haematologica
|
April 23, 2010
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes
Cristina Gattazzo, Antonella Teramo, Marta Miorin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 5, 2009
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis
Carmela Gurrieri, Francesco Piazza, Marianna Gnoato, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
March 6, 2004
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
Livio Trentin, Anna Cabrelle, Monica Facco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis
Isabella Dell'Aica, Raffaele Niero, Francesco Piazza, et al.
Thorax
|
December 9, 2010
Sarcoidosis is a Th1/Th17 multisystem disorder
Monica Facco, Anna Cabrelle, Antonella Teramo, et al.
BMC Cancer
|
October 6, 2010
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Francesco Piazza, Sabrina Manni, Laura Quotti Tubi, et al.
Journal of Leukocyte Biology
|
July 7, 2007
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis
Monica Facco, Ilenia Baesso, Marta Miorin, et al.
Plos One
|
July 7, 2012
HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen
Federica Frezzato, Cristina Gattazzo, Veronica Martini, et al.
British Journal of Haematology
|
August 10, 2007
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity
Livio Trentin, Marta Miorin, Monica Facco, et al.
Blood
|
May 17, 2003
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes
Renato Zambello, Michela Falco, Mariella Della Chiesa, et al.
Haematologica
|
April 23, 2010
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes
Cristina Gattazzo, Antonella Teramo, Marta Miorin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 5, 2009
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis
Carmela Gurrieri, Francesco Piazza, Marianna Gnoato, et al.
Page
of 5